Managing Side Effects of Alpelisib in Breast Cancer Therapy
Alpelisib, known commercially as Vijoice, offers a targeted therapeutic option for advanced breast cancer treatments, particularly in HR-positive, HER2-negative, and PIK3CA-mutated cases. This treatment, however, presents both common and serious side effects requiring close patient monitoring and precautions. From managing severe reactions to understanding contraindications, exploring these aspects equips patients and professionals alike with the […]
3 minute read